Login
Home
Charts
Search
Watchlist
Products

Relaxo Footwears Ltd

RELAXO·NSE
298.30+1.93%Wed, 23 Sept '26

Relaxo Footwears Ltd

RELAXO
NSE
298.30
+1.93%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7,426Cr
Close
Close Price
298.30
Industry
Industry
Footwear
PE
Price To Earnings
40.04
PS
Price To Sales
2.70
Revenue
Revenue
2,753Cr
Rev Gr TTM
Revenue Growth TTM
2.11%
PAT Gr TTM
PAT Growth TTM
5.98%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
715713747748679667695654629668751705
Growth YoY
Revenue Growth YoY%
6.84.7-2.31.3-5.0-6.4-7.0-12.5-7.50.28.17.7
Expenses
ExpensesCr
624626627649592584583555547599627597
Operating Profit
Operating ProfitCr
9287120998883112998169124108
OPM
OPM%
12.812.216.113.212.912.516.115.212.910.416.515.3
Other Income
Other IncomeCr
116557781112111213
Interest Expense
Interest ExpenseCr
555555555566
Depreciation
DepreciationCr
373838394040394039393940
PBT
PBTCr
605182605045756649369175
Tax
TaxCr
16122116131219171392320
PAT
PATCr
443961443733564936276855
Growth YoY
PAT Growth YoY%
97.328.1-3.0-21.2-16.9-14.4-8.410.2-1.6-19.620.412.3
NPM
NPM%
6.25.48.25.95.45.08.17.55.84.09.07.8
EPS
EPS
1.81.62.51.81.51.32.32.01.51.12.72.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
715713747748679667695654629668751705
Growth YoY
Revenue Growth YoY%
6.84.7-2.31.3-5.0-6.4-7.0-12.5-7.50.28.17.7
Expenses
ExpensesCr
624626627649592584583555547599627597
Operating Profit
Operating ProfitCr
9287120998883112998169124108
OPM
OPM%
12.812.216.113.212.912.516.115.212.910.416.515.3
Other Income
Other IncomeCr
116557781112111213
Interest Expense
Interest ExpenseCr
555555555566
Depreciation
DepreciationCr
373838394040394039393940
PBT
PBTCr
605182605045756649369175
Tax
TaxCr
16122116131219171392320
PAT
PATCr
443961443733564936276855
Growth YoY
PAT Growth YoY%
97.328.1-3.0-21.2-16.9-14.4-8.410.2-1.6-19.620.412.3
NPM
NPM%
6.25.48.25.95.45.08.17.55.84.09.07.8
EPS
EPS
1.81.62.51.81.51.32.32.01.51.12.72.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7121,6311,9412,2922,4102,3592,6532,7832,9142,7902,7022,753
Growth
Revenue Growth%
15.6-4.719.018.15.2-2.112.54.94.7-4.3-3.12.1
Expenses
ExpensesCr
1,4721,4001,6391,9682,0021,8642,2382,4472,5072,4082,3282,370
Operating Profit
Operating ProfitCr
240231302324409495416336407382374383
OPM
OPM%
14.014.215.614.217.021.015.712.113.913.713.813.9
Other Income
Other IncomeCr
814413923241929274648
Interest Expense
Interest ExpenseCr
2315971717151919212222
Depreciation
DepreciationCr
47515462109110114125147158157158
PBT
PBTCr
178178244268292391311210269230241251
Tax
TaxCr
5758839365100785669606265
PAT
PATCr
120120161175226292233154200170179185
Growth
PAT Growth%
16.7-0.334.38.929.028.9-20.2-33.629.8-15.05.36.0
NPM
NPM%
7.07.38.37.79.412.48.85.56.96.16.66.7
EPS
EPS
5.05.06.73.59.111.79.46.28.16.87.27.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,7121,6311,9412,2922,4102,3592,6532,7832,9142,7902,7022,753
Growth
Revenue Growth%
15.6-4.719.018.15.2-2.112.54.94.7-4.3-3.12.1
Expenses
ExpensesCr
1,4721,4001,6391,9682,0021,8642,2382,4472,5072,4082,3282,370
Operating Profit
Operating ProfitCr
240231302324409495416336407382374383
OPM
OPM%
14.014.215.614.217.021.015.712.113.913.713.813.9
Other Income
Other IncomeCr
814413923241929274648
Interest Expense
Interest ExpenseCr
2315971717151919212222
Depreciation
DepreciationCr
47515462109110114125147158157158
PBT
PBTCr
178178244268292391311210269230241251
Tax
TaxCr
5758839365100785669606265
PAT
PATCr
120120161175226292233154200170179185
Growth
PAT Growth%
16.7-0.334.38.929.028.9-20.2-33.629.8-15.05.36.0
NPM
NPM%
7.07.38.37.79.412.48.85.56.96.16.66.7
EPS
EPS
5.05.06.73.59.111.79.46.28.16.87.27.5

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121225252525252525
Reserves
ReservesCr
4685947491,0931,2481,5481,7351,8301,9762,0732,181
Current Liabilities
Current LiabilitiesCr
362360415463413449461471519451513
Non Current Liabilities
Non Current LiabilitiesCr
1561047443155154161169193214230
Total Liabilities
Total LiabilitiesCr
9971,0701,2501,6111,8412,1762,3832,4952,7142,7622,949
Current Assets
Current AssetsCr
4194475627277911,0801,1871,1941,2461,2351,194
Non Current Assets
Non Current AssetsCr
5786246888841,0501,0961,1961,3011,4681,5281,755
Total Assets
Total AssetsCr
9971,0701,2501,6111,8412,1762,3832,4952,7142,7622,949
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121225252525252525
Reserves
ReservesCr
4685947491,0931,2481,5481,7351,8301,9762,0732,181
Current Liabilities
Current LiabilitiesCr
362360415463413449461471519451513
Non Current Liabilities
Non Current LiabilitiesCr
1561047443155154161169193214230
Total Liabilities
Total LiabilitiesCr
9971,0701,2501,6111,8412,1762,3832,4952,7142,7622,949
Current Assets
Current AssetsCr
4194475627277911,0801,1871,1941,2461,2351,194
Non Current Assets
Non Current AssetsCr
5786246888841,0501,0961,1961,3011,4681,5281,755
Total Assets
Total AssetsCr
9971,0701,2501,6111,8412,1762,3832,4952,7142,7622,949

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
15918015412331951356400235406348
Investing Cash Flow
Investing Cash FlowCr
-130-89-108-57-116-45315-258-99-262-207
Financing Cash Flow
Financing Cash FlowCr
-31-89-46-68-203-56-70-138-106-162-146
Net Cash Flow
Net Cash FlowCr
-210-2141330-18-5
Free Cash Flow
Free Cash FlowCr
160904632203391-81224-10292213
CFO To PAT
CFO To PAT%
132.6150.295.870.4140.9176.024.1259.0117.3238.4194.3
CFO To EBITDA
CFO To EBITDA%
66.578.051.138.178.0103.613.5119.257.8106.393.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
15918015412331951356400235406348
Investing Cash Flow
Investing Cash FlowCr
-130-89-108-57-116-45315-258-99-262-207
Financing Cash Flow
Financing Cash FlowCr
-31-89-46-68-203-56-70-138-106-162-146
Net Cash Flow
Net Cash FlowCr
-210-2141330-18-5
Free Cash Flow
Free Cash FlowCr
160904632203391-81224-10292213
CFO To PAT
CFO To PAT%
132.6150.295.870.4140.9176.024.1259.0117.3238.4194.3
CFO To EBITDA
CFO To EBITDA%
66.578.051.138.178.0103.613.5119.257.8106.393.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4,3695,9697,8409,61314,82521,71826,51621,13220,31310,1285,9227,426
Price To Earnings
Price To Earnings
36.849.748.654.865.574.5113.9136.7101.459.533.040.0
Price To Sales
Price To Sales
2.53.74.04.26.29.210.07.67.03.62.22.7
Price To Book
Price To Book
9.19.810.38.711.713.815.111.410.24.82.73.4
EV To EBITDA
EV To EBITDA
19.126.426.429.936.644.164.263.250.227.016.419.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.642.642.139.141.444.239.136.540.941.341.641.6
OPM
OPM%
14.014.215.614.217.021.015.712.113.913.713.813.9
NPM
NPM%
7.07.38.37.79.412.48.85.56.96.16.66.7
ROCE
ROCE%
29.426.128.423.121.923.816.911.313.110.810.810.8
ROE
ROE%
25.119.821.215.917.818.513.28.310.08.18.18.1
ROA
ROA%
12.111.212.910.912.313.49.86.27.46.26.16.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4,3695,9697,8409,61314,82521,71826,51621,13220,31310,1285,9227,426
Price To Earnings
Price To Earnings
36.849.748.654.865.574.5113.9136.7101.459.533.040.0
Price To Sales
Price To Sales
2.53.74.04.26.29.210.07.67.03.62.22.7
Price To Book
Price To Book
9.19.810.38.711.713.815.111.410.24.82.73.4
EV To EBITDA
EV To EBITDA
19.126.426.429.936.644.164.263.250.227.016.419.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.642.642.139.141.444.239.136.540.941.341.641.6
OPM
OPM%
14.014.215.614.217.021.015.712.113.913.713.813.9
NPM
NPM%
7.07.38.37.79.412.48.85.56.96.16.66.7
ROCE
ROCE%
29.426.128.423.121.923.816.911.313.110.810.810.8
ROE
ROE%
25.119.821.215.917.818.513.28.310.08.18.18.1
ROA
ROA%
12.111.212.910.912.313.49.86.27.46.26.16.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Relaxo Footwears is India’s largest footwear manufacturer, built on a simple idea that has held for nearly five decades: make everyday footwear affordable enough for the mass market, but control every step of production so quality never slips. Founded in 1976 by a rubber technologist and still family-run with professional management, the company has grown from a single slipper brand into a multi-brand powerhouse that sells roughly 17.5 crore pairs a year - all from its own factories, with no debt on the books. The recurring approach is to own the entire chain from design to distribution, build brands that ladder consumers from entry-level to premium, and fund expansion entirely through internal cash generation. # Business segments A single-engine footwear business that operates through three consumer brands at different price tiers - a mass-market cash cow, a youth-focused mid-tier engine, and a premium challenger brand - all fed by the same in-house manufacturing backbone and pushed through one nationwide distribution network. ## 1. Hawai: the mass-market foundation **The Relaxo and Bahamas brands together sell roughly 45% of all pairs the company makes, anchoring the business in the affordable rubber slipper category where the company first built its name.** - **The original household icon** - Relaxo is a rubber hawai slipper brand with over four decades of consumer trust, positioned on durability with the tagline “मज़बूती बेमिसाल” and described as the most versatile footwear across all segments of society. - **Youthful flip-flops at the same price point** - Bahamas is a colourful range of casual flip-flops aimed at young trendsetters, endorsed by Salman Khan, so the company captures younger buyers without leaving the mass price band. ## 2. Flite: the middle-class upgrade engine **Flite is India’s most popular footwear brand among the middle class, converting customers who start with rubber slippers into buyers of fashionable EVA and PU footwear at a slightly higher price.** - **Fashion at an everyday price** - Flite offers semi-formal slippers for daily wear with the tagline “SAR UTHA, KADAM BADHA,” reflecting the aspirations of today’s youth, and has been endorsed by Ranveer Singh to reinforce that style positioning. - **Polymer know-how keeps costs down** - the company uses polymer blends and pour molding technology to manufacture EVA slippers, which means it can produce a lighter, more cushioned product without relying on natural rubber. - **Volume-led partner incentives** - trade discounts are a fixed percentage of the wholesale price regardless of price point, so channel partners earn more when they sell more pairs, aligning their interests with Flite’s volume growth rather than price hikes. ## 3. Sparx: the premium challenger **Sparx is the company’s push into closed footwear - sneakers, sports shoes, and sandals - where it competes at price points up to ₹2,800 MRP and builds a younger, more aspirational customer base.** - **Built for go-getters** - Sparx is positioned as a bold, dynamic brand for young India, endorsed by Akshay Kumar, and described as one of the most loved footwear brands in the country. - **Longer design cycles for a different product** - developing a Sparx product takes 7-8 months from concept to launch, compared to 2-3 months for basic Hawai slippers, because closed footwear requires more complex design, tooling, and testing. - **E-commerce opens the premium window** - most online sales of closed footwear happen between ₹1,000 and ₹2,000 MRP, and Sparx is extending its range up to ₹2,800, so the brand can reach customers who discover footwear through Flipkart or Amazon rather than a neighbourhood store. # Manufacturing backbone **Nine company-owned factories produce roughly 10.5 lakh pairs a day, giving Relaxo end-to-end control over quality, cost, and speed that no outsourced competitor can match.** - **Everything under one roof** - the company handles designing, material management, production, packaging, and finished goods across plants in Bahadurgarh, Bhiwadi, and Haridwar, so it monitors quality at every stage rather than relying on third-party suppliers. - **Lean production for low-cost output** - dedicated lines for fast-moving SKUs, Maynard Operation Sequence Technique (MOST), and yield improvement programmes squeeze waste out of the system, which is how the company keeps prices affordable while absorbing input cost increases. - **Designs as a defensible asset** - the company holds 1,356 registered designs and 87 trademarks, so competitors cannot legally copy its bestselling patterns, protecting the shelf appeal that drives consumer pull. - **Green energy lowers long-term cost** - a 6 MW wind power project in Rajasthan has been running since 2010, and a group captive solar SPV (Clean Max MUOI Private Limited) was incorporated on June 13, 2026 to supply renewable power to Haryana plants, reducing dependence on grid electricity. # Distribution engine **A network of 630 distributors, 70,000-plus retailers, and 420 exclusive brand outlets pushes footwear into every corner of India, while a retailer app and loyalty platform keep the channel loyal.** - **General trade still dominates** - 74% of revenue flows through wholesale distributors to multi-brand retail outlets, with the strongest footprint in North India (52% of general trade sales), so the company’s fortunes rest on its ability to keep neighbourhood shoe shops stocked and motivated. - **The digital glue for 70,000 shops** - the ‘Relaxo Parivaar’ app connects retailers directly to the company for communication and rewards tracking, turning a fragmented network of small stores into a managed channel that can be activated for launches and promotions. - **Exclusive stores as brand billboards** - 420 company-branded outlets serve as physical showcases where consumers experience the full range, and the company opened its first consumer experience store in Delhi to test a more immersive retail format. - **Exports as a small but growing side door** - the company ships to about 37 countries across six continents from a Dubai office, contributing roughly 4.5% of turnover, and has been recognised as the No. 1 exporter in non-leather footwear by the Council for Leather Exports. # Group structure and partners **Relaxo is a single legal entity with no subsidiaries or joint ventures, run by a family board with deep footwear experience and a newly formed associate for captive solar power.** - **One company, one segment** - the entire business is reported as a single operating segment called “Footwear and related products,” with no subsidiaries, joint ventures, or associate companies through FY25. - **Four decades of experience in the boardroom** - the Chairman and Managing Director has 48 years in the footwear industry, and the four whole-time directors bring between 23 and 51 years each, so operational decisions are made by people who have lived through multiple raw-material cycles. - **A solar SPV for cheaper power** - in mid-2026, the company committed to taking a roughly 26% stake in Clean Max MUOI Private Limited, a special purpose vehicle that will build and operate a group captive solar project to supply renewable energy to its Haryana factories.

Documents — Relaxo Footwears Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/318j4mqewpw5nxlgr4g63a36.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/j6dvwtagwp3ze7zou7wb9e2o.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/ixo3fdsfrkdvyrt1dlv4z5mp.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/f10qbwk7fiy6cjpg2l6v4s6f.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/o70cgw1kr0si0dwx3pwa6tjn.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/3d6wyu232dvzh263crc0kui0.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/baagdpjpo8j1nm9xsw86nmlr.pdf
  • Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/balt70wy35ddzhwecniq0fka.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/6w0pjm9br2s3uhjvcackemus.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/np7bz0a1kh3odouzja6jamvs.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/m3mb1tn6l0bzxsg0s1zura38.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/mckctd4drgdmod3wyvmakzrg.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/zzlq5hlwo7xpfzxlcz2hdmig.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/r1ovj060ybfexk7jrug1zk7t.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/4gyoswxtmlfjm16bgfrss80o.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/rj9wjkuxrgs8tetpbg0w6qfz.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/7j0hy5egs7rra6g7a8dzkekn.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/9xonn9jwo6cqmhm8pikghbz0.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/1tt4rbvh03mtxt4lzfm6uut2.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/0r1xyczxnkzs4muf86xty57i.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/5d0rp9f49i1eqmbi672a8myf.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/5aexvgyzc2u4nzidrtyejd26.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/06mbvmpb4fvha09hry2pu7nr.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/2nlz2uchwt5ditt12zv0jn9o.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/yf9gvdpu6f0avt7t3yj4i2x2.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/549ttoxqebdcpp7nv1jb9ms3.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/ho4p5secpe4tmqi6pii7gcl3.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/vurltszhg76ngwzl9ygttcdo.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/brrn8jkm3lljbukte2nmu98q.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/sygfcuf03rylxpwa2dysg5nm.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/7plsfhjswmkuecerspaxogv7.pdf

Concall Transcript Summaries — Relaxo Footwears Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202603/318j4mqewpw5nxlgr4g63a36.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202509/j6dvwtagwp3ze7zou7wb9e2o.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202503/ixo3fdsfrkdvyrt1dlv4z5mp.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202409/f10qbwk7fiy6cjpg2l6v4s6f.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202403/o70cgw1kr0si0dwx3pwa6tjn.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202309/3d6wyu232dvzh263crc0kui0.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202303/baagdpjpo8j1nm9xsw86nmlr.pdf
  • Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/NSE%3ARELAXO/transcript-notes/202209/balt70wy35ddzhwecniq0fka.pdf